Abstract
Movement disorders is not an area of neurology known to have many clinical emergencies. However, their recognition is very important since urgent care can be needed in these cases. In this chapter we will review the more frequent and more severe emergencies in movement disorders, going from their cause to the diagnosis and treatment approach. For practical purposes, we will classify movement disorders emergencies in either hypokinetic or hyperkinetic. As it is the case for all movement disorders, careful history of the patient and physical examination is key to a correct identification of the problem and treatment strategy approach. For acute movement disorders presenting in the Emergency Department or in the hospital, a diligent review of medications taken by the patients is particularly necessary.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Poston KL, Frucht SJ. Movement disorder emergencies. J Neurol. 2008;255(Suppl 4):2–13.
Munhoz RP, Scorr LM, Factor SA. Movement disorders emergencies. Curr Opin Neurol. 2015;28(4):406–12.3.
Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77(1):185–202.
Shalev A, Munitz H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatr Scand. 1986;73:337–47.
Hashim H, Zeb-un-Nisa ASA, Al Madani AA. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy. J Pak Med Assoc. 2014 Apr;64(4):471–3.
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112.
Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148:705–13.
Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635–42.
Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004;42:277–85.
Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract. 1999;49:871–4.
Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A, DIGPD Study Group. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology. 2018. [Epub ahead of print].
Rabinak CA, Nirenberg MJ. Dopamine Agonist Withdrawal Syndrome in Parkinson Disease. Arch Neurol. 2010;67(1):58–63.
Genel F, Arslanoglu S, Uran N, Saylan B. Sydenham’s chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain and Development. 2002;24(2):73–6.
Oh SH, Lee KY, Im JH, Lee MS. Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: meta-analysis of 53 cases including four present cases. J Neurol Sci. 2002;200(1–2):57–62.
Manji H, Howard RS, Miller DH, et al. Status dystonicus: the syndrome and its management [published correction appears in Brain. 2000;123(pt 2):419]. Brain. 1998;121(pt 2):243–52.
Wijdicks EFM, Hijdra A, Young GB, Bassetti CL, Wiebe S. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;67(2):203–10.
Braksick SA, Rabinstein AA, Wijdicks EF, Fugate JE, Hocker S. Post-ischemic myoclonic status following cardiac arrest in young drug users. Neurocrit Care. 2017;26(2):280–3.
Dalic LJ, Fennessy G, Edmonds M, Carney P, Opdam H, Archer J. Early electroencephalogram does not reliably differentiate outcomes in post-hypoxic myoclonus. Crit Care Resusc. 2019;21(1):45–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Arena, J.E. (2020). Emergencies in Movement Disorders. In: Rabinstein, A. (eds) Neurological Emergencies. Springer, Cham. https://doi.org/10.1007/978-3-030-28072-7_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-28072-7_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28071-0
Online ISBN: 978-3-030-28072-7
eBook Packages: MedicineMedicine (R0)